Bevacirel 400 mg Injection
  1. Home
  2. Pharma Products
  3. Reliance Life Sciences Pvt Ltd
  4. Bevacirel 400 mg Injection

Bevacirel 400 mg Injection

Bevacirel 400 mg Injection contains bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It works by blocking VEGF, which helps reduce the formation of blood vessels that supply tumors. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Bevacirel 400 mg Injection contains 400 mg of bevacizumab in a 16 mL single-use vial. Bevacizumab inhibits VEGF activity and can limit the blood supply that supports tumor growth. It is used in approved treatment regimens for cancers including colorectal, non-small cell lung, renal, ovarian, cervical, and other specified cancers. The product should be refrigerated at 2°C to 8°C and administered intravenously according to the prescribed oncology protocol.

Technical Specification

Specification Details
Active Ingredient Bevacizumab 400 mg
Concentration 25 mg/mL
Vial Volume 16 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Storage 2°C to 8°C

Product Also Known As

Bevacirel 400 mg Injection, Bevacirel 400 mg/16 mL Injection, Bevacirel Bevacizumab 400 mg Injection, Bevacizumab 400 mg Injection, Bevacizumab 400 mg Infusion, Bevacizumab Oncology Injection